Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 297

Cited In for PubMed (Select 12517460)

1.

The relationship between neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and thrombolysis in myocardial infarction risk score in patients with ST elevation acute myocardial infarction before primary coronary intervention.

Acet H, Ertaş F, Bilik MZ, Akıl MA, Özyurtlu F, Aydın M, Oylumlu M, Polat N, Yüksel M, Yıldız A, Kaya H, Akyüz A, Ayçiçek H, Özbek M, Toprak N.

Postepy Kardiol Interwencyjnej. 2015;11(2):126-35. doi: 10.5114/pwki.2015.52286. Epub 2015 Jun 22.

2.

Preliminary experience with drug-coated balloon angioplasty in primary percutaneous coronary intervention.

Ho HH, Tan J, Ooi YW, Loh KK, Aung TH, Yin NT, Sinaga DA, Jafary FH, Ong PJ.

World J Cardiol. 2015 Jun 26;7(6):311-4. doi: 10.4330/wjc.v7.i6.311. Review.

3.

Recent advances in the diagnosis and treatment of acute myocardial infarction.

Reddy K, Khaliq A, Henning RJ.

World J Cardiol. 2015 May 26;7(5):243-76. doi: 10.4330/wjc.v7.i5.243. Review.

4.

Admission glucose and risk of early death in non-diabetic patients with ST-segment elevation myocardial infarction: a meta-analysis.

Zhao CJ, Hao ZX, Liu R, Liu Y.

Med Sci Monit. 2015 May 14;21:1387-94. doi: 10.12659/MSM.894249.

5.

The 7-year teesside experience of primary prevention ICD indications following primary PCI (PPCI) and the potential impact of a change in NICE guidance.

Phan TT, Khan S, Mahmood MM, Mani S, Wadehra V, de Belder M, Thornley A, James S, Linker NJ, Turley AJ.

Open Heart. 2015 Apr 24;2(1):e000153. doi: 10.1136/openhrt-2014-000153. eCollection 2015.

6.

High tenascin-C levels cause inadequate myocardial blush grade in patients with acute myocardial infarction.

Arican Ozluk O, Topal D, Tenekecioglu E, Peker T, Yilmaz M, Karaagac K, Vatansever F, Boyraz B, Aydın O.

Int J Clin Exp Med. 2015 Feb 15;8(2):2554-61. eCollection 2015.

7.

Combination therapy reduces the incidence of no-reflow after primary per-cutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction.

Zhou SS, Tian F, Chen YD, Wang J, Sun ZJ, Guo J, Jin QH.

J Geriatr Cardiol. 2015 Mar;12(2):135-42. doi: 10.11909/j.issn.1671-5411.2015.02.003.

8.

The relationship between grade of ischemia, success of reperfusion, and type of thrombolytic regimen.

Ayça B, Conkbayır C, Katkat F, Gulsen K, Akin F, Okuyan E, Baskurt M, Okcun B.

Med Sci Monit. 2015 Mar 8;21:716-21. doi: 10.12659/MSM.892645.

10.

Do we need the cardiologist in the prehospital triage for STEMI?

Verheugt FW.

Neth Heart J. 2005 Sep;13(9):293-294. No abstract available.

11.

The practicing physician's current perspective on therapeutic options in coronary artery disease.

Drenth DJ, Zijlstra F, Boonstra PW.

Neth Heart J. 2005 Aug;13(7-8):274-279. Review.

12.

Statin therapy and mortalitiy in patients with ST-segment elevation myocardial infarction treated with primary angioplasty.

De Luca G, Suryapranata H, Zijlstra F, Ottervanger JP, van 't Hof AW, Hoorntje JC, Gosselink AT, Dambrink JH, de Boer MJ.

Neth Heart J. 2004 Jun;12(6):271-278.

13.

DANAMI-2: the end of the thrombolytic era.

Petrie MC, Anthonio RL, Zijlstra F.

Neth Heart J. 2003 Nov;11(11):437-439. No abstract available.

14.

Acute stroke with concomitant acute myocardial infarction: will you thrombolyse?

Maciel R, Palma R, Sousa P, Ferreira F, Nzwalo H.

J Stroke. 2015 Jan;17(1):84-6. doi: 10.5853/jos.2015.17.1.84. Epub 2015 Jan 30. No abstract available.

16.

Comparison of the hospital arrival time and differences in pain quality between diabetic and non-diabetic STEMI patients.

Gradišer M, Dilber D, Cmrečnjak J, Ostrički B, Bilić-Ćurčić I.

Int J Environ Res Public Health. 2015 Jan 27;12(2):1387-96. doi: 10.3390/ijerph120201387.

17.

Management and outcomes of acute ST-segment-elevation myocardial infarction at a tertiary-care hospital in Sri Lanka: an observational study.

Bandara R, Medagama A, Munasinghe R, Dinamithra N, Subasinghe A, Herath J, Ratnayake M, Imbulpitiya B, Sulaiman A.

BMC Cardiovasc Disord. 2015 Jan 15;15:1. doi: 10.1186/1471-2261-15-1.

18.

Cellular postconditioning: allogeneic cardiosphere-derived cells reduce infarct size and attenuate microvascular obstruction when administered after reperfusion in pigs with acute myocardial infarction.

Kanazawa H, Tseliou E, Malliaras K, Yee K, Dawkins JF, De Couto G, Smith RR, Kreke M, Seinfeld J, Middleton RC, Gallet R, Cheng K, Luthringer D, Valle I, Chowdhury S, Fukuda K, Makkar RR, Marbán L, Marbán E.

Circ Heart Fail. 2015 Mar;8(2):322-32. doi: 10.1161/CIRCHEARTFAILURE.114.001484. Epub 2015 Jan 13.

PMID:
25587096
19.

Long-term prognostic value of admission haemoglobin A1c (HbA1c) levels in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Pusuroglu H, Akgul O, Cakmak HA, Erturk M, Surgit O, Celik O, Ozturk D, Uzun F, Akkaya E, Yildirim A.

Postepy Kardiol Interwencyjnej. 2014;10(3):166-74. doi: 10.5114/pwki.2014.45143. Epub 2014 Sep 11.

20.

Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study.

Nallamothu BK, Normand SL, Wang Y, Hofer TP, Brush JE Jr, Messenger JC, Bradley EH, Rumsfeld JS, Krumholz HM.

Lancet. 2015 Mar 21;385(9973):1114-22. doi: 10.1016/S0140-6736(14)61932-2. Epub 2014 Nov 19.

PMID:
25467573
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk